•  
  •  
  •  
  •  

2026-02-15 10:55:19

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Anupam Rasayan Delivers Strong Q3 FY26 Performance
  • Hind Rectifiers Posts Record Q3 FY26 Revenue
  • AvenuesAI Reports Record Q3 FY26 with 122% Revenue Growth
  • Vipul Organics Reports Solid Q3 FY26 Growth
  • KFin Technologies Posts Robust Q3 FY26 Growth

Keywords Selected:  ML

Research

  • Tata Motors CV Listing: A Strong Value Unlock Story
  • Kotak Institutional Equities - Banks: Jharkhand farm loan waiver: No concerns for microfinance
  • Rising frauds propel demand for AI/ML strategies: Experian Study
  • A report by TeamLease EdTech reveals that 94% of learners would like to pursue a Multidisciplinary Degree

Stock Report

  • Tata Teleservices Maharashtra Ltd Q3FY26 loss at Rs. 150.43 crores
  • SML Mahindra Ltd Q3FY26 PAT at Rs. 17.54 crores
  • SPML Infra Ltd secures arbitration award of Rs. 21.61 crore from CMWSSB
  • SML MAHINDRA LIMITED reports December 2025 Sales, with strong YoY growth
  • IRFC Sanctions ₹5,000 Crore Rupee Term Loan to MAHAGENCO, ₹3,000 Crore Disbursed
  • Shriram Pistons & Rings Ltd enters into asset purchase agreement with Sunbeam
  • Titan Intech Ltd gets in-principle approval for term loan from IDBI Bank Limited
  • BEML Limited bags order of Rs. 110 crores
  • Remedium Lifecare Ltd is now Supha Pharmachem Ltd
  • MAS Financial Services Ltd sanctions term loan of Rs. 5 crores to Akme Fintrade India Ltd
  • GMP Inspection by Malta Medicines Authority at Alkem's manufacturing facility located at Daman, India
  • Godrej Industries Group to invest over INR 10,000 crore in the state of Telangana
  • SPML Infra secures Rs. 207.38 Crore under Jal Jeevan Mission to augment Water supply in Rajasthan
  • BEML signs MoU with Sagarmala Finance Corporation Ltd
  • BEML Ltd inks tripartie MoU
  • Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg™ in the United States
  • BEML Ltd receives order valued at Rs. 157 crores
  • Suparna Mitra to join as MD & CEO of TeamLease
  • ZIM Laboratories Ltd receives approval from CDSCO - Directorate General of Health Services for Naproxen + Esomeprazole Capsules
  • BEML secures additional order from Bangalore Metro
  • Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg - Pegfilgrastim-unne
  • Maharashtra Seamless Ltd receives order from ONGC worth Rs. 217 crores
  • Completion of acquisition by CAMLIN FINE SCIENCES of a majority stake in Vinpai
  • Marico Launches Nihar Naturals Shanti Aloe Vera Amla Hair Oil; Reimagines Traditional Haircare for the Modern Indian Woman

Industry News

  • Premium Lingerie Brand MHYTH Raises Angel Funding, achieves Over $1M Valuation Within a month of launch
  • Shriram life launches golden jubilee plan with life goal & legacy options
  • Shriram Life gets PFRDA nod to become annuity service provider
  • Shriram Life Launches Shriram Life Premier Assured Benefit
  • Shriram Life Insurance adopts technology-driven eKYC services

Latest Post

  • Anupam Rasayan Delivers Strong Q3 FY26 Performance
  • Hind Rectifiers Posts Record Q3 FY26 Revenue
  • AvenuesAI Reports Record Q3 FY26 with 122% Revenue Growth
  • Vipul Organics Reports Solid Q3 FY26 Growth
  • KFin Technologies Posts Robust Q3 FY26 Growth


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025